Nakamura A, Tanaka J, Yuki R, Nakayama Y.
Targeting EphA2 under DNA damage causes mitotic bypass via p21 induction. J. Biol. Chem., 2026, accepted. https://doi.org/10.1016/j.jbc.2026.111271
Takada M, Murata M, Soeda S, Honda T, Yuki R, Nakayama Y.
Upregulation of EphA2 by Src counteracts Src-induced loss of cell adhesion. Exp. Cell Res., 456: 114898, 2026. https://doi.org/10.1016/j.yexcr.2026.114898
Yuki R, Saito Y, Nakayama Y.
Targeting the splicing factor CWC22 induces mitotic slippage through repression of BubR1 expression and CDK1 activity in cancer cells. J. Biol. Chem., 302: 111148, 2026. https://doi.org/10.1016/j.jbc.2026.111148
Josen T, Yuki R, Saito Y, Honda T, Soeda S, Nakayama Y.
The Aurora B inhibitor ZM-447439 induces caspase-independent necrosis-like death in v-Src oncogene-expressing cells via accumulation of extra-lysosomal cathepsin B. Exp. Cell Res., 454: 114840, 2026. https://doi.org/10.1016/j.yexcr.2025.114840
Kawaji R, Yuki R, Saito Y, Nakayama Y.
Suppression of the lipid-transport activity of OSBPL11 weakens the cytotoxicity of SAC-activating drugs by promoting mitotic slippage. Biochem. Biophys. Res. Commun., 794:153045, 2026. https://doi.org/10.1016/j.bbrc.2025.153045
Kaibori Y, Kuga T, Nakayama Y, Yamagishi N, Nagakubo D.
Establishment of γ-secretase–deficient goblet-like cells: A novel in vitro platform to dissect regulatory mechanisms of mucus production in the intestinal epithelium. Biochem. Biophys. Res. Commun., 794:153091, 2026. https://doi.org/10.1016/j.bbrc.2025.153091